Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,241 | -35,836 | -16,934 | -48,607 | -32,052 |
| Depreciation Amortization | -6,215 | -4,654 | -2,195 | -2,818 | -1,367 |
| Accounts receivable | N/A | -90 | N/A | N/A | -1 |
| Accounts payable and accrued liabilities | 834 | 1,249 | 1,417 | 2,012 | 630 |
| Other Working Capital | -1,990 | -5,392 | -8,397 | 3,439 | 854 |
| Other Operating Activity | 5,561 | 2,591 | 97 | 295 | 902 |
| Operating Cash Flow | $-58,051 | $-42,132 | $-26,012 | $-45,679 | $-31,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -311,644 | -343,648 | -307,432 | -121,195 | -136,729 |
| PPE Investments | -25 | -26 | -12 | 0 | N/A |
| Investing Cash Flow | $-311,669 | $-343,674 | $-307,444 | $-121,195 | $-136,729 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -365 | -365 | -365 | -16,291 | -16,284 |
| Common Stock Issued | 408,654 | 406,487 | 406,410 | 2,082 | 1,820 |
| Other Financing Activity | -3,424 | -3,424 | -3,387 | 101,206 | 104,357 |
| Financing Cash Flow | $404,865 | $402,698 | $402,658 | $86,997 | $89,893 |
| Beginning Cash Position | 8,266 | 8,266 | 8,266 | 88,143 | 88,143 |
| End Cash Position | 43,411 | 25,158 | 77,468 | 8,266 | 10,273 |
| Net Cash Flow | $35,145 | $16,892 | $69,202 | $-79,877 | $-77,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,051 | -42,132 | -26,012 | -45,679 | -31,034 |
| Capital Expenditure | -25 | -26 | -12 | N/A | N/A |
| Free Cash Flow | -58,076 | -42,158 | -26,024 | -45,679 | -31,034 |